Key Takeaways
- The hallmark symptoms are vulvar and vaginal itching, burning, redness, and thick white clumpy discharge without odor.[1]
- About 75 percent of women will have at least one episode, and the fungus is usually Candida albicans (85 to 95 percent of cases).[3]
- The dominant risk factors are antibiotics, diabetes, pregnancy, and immune suppression, all of which tip the vaginal ecosystem toward fungal overgrowth.[8]
- A normal vaginal pH below 4.5 plus yeast seen on microscopy is the cornerstone of diagnosis and separates yeast from bacterial vaginosis.[1][7]
- Self-diagnosis is unreliable: over half of women who think they have a yeast infection do not.[6]
- Recurrent episodes (four or more a year) affect up to 9 percent of women and warrant evaluation for underlying diabetes or a resistant strain.[4][8]
Vaginal symptoms are among the most common reasons people seek care, and the single biggest barrier to effective treatment is that several different conditions feel almost identical. What one person calls a yeast infection may in fact be bacterial vaginosis, irritation from a product, vulvar skin disease, or the dryness that comes with menopause. This guide focuses on what a vaginal yeast infection actually is, the symptoms and causes, and the steps a clinician takes to be sure.
What Is a Vaginal Yeast Infection?
A vaginal yeast infection, or vulvovaginal candidiasis (VVC), is inflammation of the vulva and vagina caused by overgrowth of Candida, a yeast that is normally present in small amounts in the vagina, the gastrointestinal tract, and on the skin. Under the right conditions the yeast transitions from its harmless round form into an invasive thread-like (hyphal) form that penetrates the vaginal lining and triggers the characteristic itching, burning, and discharge.[3]
It is important to place the term carefully. A vaginal yeast infection is distinct from oral candidiasis (thrush), male genital candidiasis (balanitis on the glans of the penis), and invasive candidiasis, which is a serious bloodstream infection seen mainly in hospitalized or immunosuppressed patients. VVC is a localized, usually minor infection of the vulvovaginal area, but it can be intensely uncomfortable.[2]
Nearly every part of the epidemiology points to how common it is. Roughly 75 percent of women have at least one episode in their lifetime, about 40 to 50 percent have two or more, and 5 to 9 percent develop the recurrent form, defined as four or more episodes a year.[3][4] A global systematic review estimated recurrent vulvovaginal candidiasis alone affects about 138 million women annually.[5]
Symptoms
The symptom signature of VVC is dominated by itch and burning, and the discharge is distinctive:
- Itching (pruritus) of the vulva and vagina, often severe and the symptom that usually brings people to care
- Burning of the vulva and vaginal opening, sometimes felt with urination as urine contacts inflamed skin
- Thick, white, clumpy discharge, classically described as cottage-cheese-like, with little or no odor
- Redness, swelling, and irritation of the vulva (erythema and edema), which can progress to small fissures or excoriations from scratching
- Pain during sex (dyspareunia) and general soreness
The absence of odor matters. A strong fishy smell points toward bacterial vaginosis, and a frothy yellow-green discharge points toward trichomoniasis, not yeast.[1]
How Severe Is It
Guidelines divide VVC into uncomplicated and complicated categories because they predict how treatment should go.[2]
- Uncomplicated: sporadic, mild to moderate symptoms in an otherwise healthy, non-pregnant woman, caused by C. albicans, with a vaginal pH below 4.5. This is the category most home and OTC treatments are aimed at.
- Complicated: severe symptoms (widespread redness, swelling, skin breakdown), recurrent disease, non-albicans species such as C. glabrata, pregnancy, poorly controlled diabetes, or immunocompromise. These need longer or different treatment.[2]
Uncomplicated vs Complicated Infection
| Feature | Uncomplicated | Complicated |
|---|---|---|
| Frequency | Sporadic | Recurrent (4+ per year)[2] |
| Severity | Mild to moderate | Severe erythema, edema, fissures |
| Organism | Usually C. albicans | Often non-albicans or resistant[10] |
| Host | Healthy, non-pregnant | Pregnant, diabetic, or immunosuppressed |
| Treatment | Short-course azole | Longer or alternative therapy[2] |
Causes and Risk Factors
The vagina is normally dominated by Lactobacillus bacteria that produce lactic acid and keep the environment acidic, hostile to fungal overgrowth. VVC develops when something disturbs that balance or weakens the immune defenses that contain Candida.[3][9]
Antibiotics. The single most common trigger. Antibiotics reduce protective lactobacilli, and yeast, which is not affected by antibiotics, expands into the gap. The infection typically appears during or shortly after a course taken for a urinary tract, sinus, or dental infection.[8]
Estrogen and hormones. Estrogen encourages Candida growth, which is why VVC peaks in the reproductive years, is more common in pregnancy and in the days before menstruation, and becomes rare after menopause in women not using estrogen therapy.[3] Higher-estrogen oral contraceptives are an occasional contributor.[8]
Diabetes. Poorly controlled diabetes, especially with chronically high blood sugar, promotes yeast growth and blunts the immune response. Recurrent infection should trigger screening for diabetes, because controlling glucose is one of the few interventions proven to reduce relapse.[8]
Immunosuppression. HIV, chemotherapy, organ transplant medicines, and long-term steroids raise the risk of more severe and recurrent infection.[2]
Behavioral factors. Douching and scented products can disturb the flora, and tight, non-breathable, or persistently damp clothing is often blamed, though the evidence for the clothing factor is modest. The strongest contributing behaviors are douching and unnecessary antibiotic use.[3]
Risk Factor Comparison
| Risk factor | How it predisposes | Strength of evidence |
|---|---|---|
| Antibiotic use | Kills protective lactobacilli, letting yeast expand | Strong, well documented[8] |
| Diabetes (poor control) | High glucose feeds yeast and impairs immunity | Strong[8] |
| Pregnancy | High estrogen promotes fungal growth | Strong[11] |
| Immunosuppression | Reduced immune control of Candida | Strong[2] |
| Estrogen contraception / HRT | Estrogen supports the fungus | Moderate[8] |
| Douching, scented products | Disrupt vaginal flora | Moderate[3] |
| Tight or damp clothing | Warmth and moisture | Weak, mostly anecdotal[3] |
How It Is Diagnosed
An accurate diagnosis has three parts: the history and symptom pattern, the vaginal pH, and microscopic examination of the discharge.
Vaginal pH. A quick office test measures acidity. VVC keeps the pH in the normal range below 4.5, whereas bacterial vaginosis and trichomoniasis raise it above 4.5. This single, inexpensive step is the first fork in the road.[1]
Microscopy. A sample is mixed with potassium hydroxide, which dissolves human cells and leaves the fungus visible. Finding budding yeast and pseudohyphae confirms candidiasis.[7] The test is quick but can be negative in some true infections, which is why culture or molecular testing is sometimes added.
Culture and sensitivity. Reserved for cases that fail treatment or recur, culture grows the organism and identifies the exact species and which antifungals it is sensitive to. This is essential for non-albicans species that resist azoles.[2][10]
Three Steps in Diagnosis
| Step | What it measures | Typical result in yeast |
|---|---|---|
| Vaginal pH | Acidity of vaginal fluid | Below 4.5 (normal)[1] |
| Potassium hydroxide (KOH) microscopy | Yeast visible in discharge | Budding yeast and pseudohyphae[7] |
| Culture and sensitivity | Exact species and drug sensitivity | Used for recurrent or treatment-resistant cases[2] |
Is It Something Else
Three conditions produce most vaginal discharge and irritation, and two other non-infectious causes are easily missed:
- Bacterial vaginosis (BV): thin, gray-white discharge with a fishy odor, pH above 4.5, and clue cells on microscopy. Treated with metronidazole or clindamycin, not antifungals.
- Trichomoniasis: frothy yellow-green discharge, vulvar soreness, pH above 4.5, and motile parasites on microscopy. A sexually transmitted infection needing metronidazole or tinidazole, and partner treatment.
- Contact dermatitis: irritation from soaps, detergents, sanitary products, or spermicides can mimic yeast, with itching and burning and a normal pH and microscopy.
- Vaginal dryness and genitourinary syndrome of menopause: postmenopausal thinning causes burning and discomfort that is often mistaken for infection. It responds to moisturizers and vaginal estrogen, not antifungals. See our vaginal dryness treatment guide.
For the direct head-to-head of the two most commonly confused infections, read yeast infection vs BV and the bacterial vaginosis guide.
Self-Assessment vs Clinician Visit
Over-the-counter antifungals are safe and effective for uncomplicated infection, but the catch is knowing you actually have one. In a multicenter study, only 34 percent of women who self-diagnosed a yeast infection had it confirmed; the rest had BV, mixed infection, or no infection at all. Another analysis found self-diagnosis was accurate in only about a third of cases.[6][7]
A reasonable rule of thumb: if you have had a yeast infection confirmed before, recognize the exact same symptoms, and have no complicating factors, a short OTC azole course is reasonable. If it is a first episode, the symptoms are unusual, there is odor or pelvic pain, or symptoms have not improved in a few days of treatment, see a clinician.[1]
Treatment at a Glance
Treatment is a short course of an azole antifungal. For uncomplicated infection this is either a single 150 mg oral dose of fluconazole or a topical regimen such as miconazole, clotrimazole, or terconazole, with cure rates around 80 to 90 percent.[1] Complicated cases need longer courses, and non-albicans or resistant infections need alternatives such as boric acid.[10] The full treatment framework, with dosing and comparison tables, is in the main yeast infection guide.
Prevention
- Use antibiotics only when truly needed
- Keep blood sugar controlled if you have diabetes
- Avoid douching and scented feminine-hygiene products
- Change out of wet or sweaty clothing promptly and favor breathable cotton underwear
- Do not treat sex partners, as partner treatment does not prevent recurrence[1]
Red Flags: When to See a Clinician
Seek care when symptoms do not improve in a few days, recur frequently, or are accompanied by fever, pelvic pain, malodorous discharge, or any sign suggesting a urinary tract or pelvic infection. Repeated episodes also warrant a check for diabetes and possibly culture to look for a resistant or non-albicans strain.[8][10]
Frequently Asked Questions
The classic picture is intense vulvar and vaginal itching, burning, redness, and thick white clumpy discharge with no odor. Because these symptoms overlap with other conditions, a clinician confirms the diagnosis with a vaginal pH below 4.5 and yeast seen on microscopy.[1]
It is typically thick, white, and clumped, often compared to cottage cheese, and usually odorless. Bacterial vaginosis, by contrast, produces a thin gray-white discharge with a fishy odor.[1]
Yes, antibiotics are the most common trigger. They reduce the protective lactobacilli that keep Candida in check, allowing the fungus to overgrow during or just after the antibiotic course.[8]
Not in the way a cold or most STIs are. The yeast is already present in the body, and the infection reflects overgrowth, not a new acquisition. It is not classified as a sexually transmitted infection, and partner treatment does not reduce recurrence.[1]
Estrogen levels rise in the days before menstruation, and estrogen promotes Candida growth in the vagina. This hormonal peak is a common, well-recognized trigger for women prone to these infections.[3]
Yes. Poorly controlled diabetes, with chronically elevated blood sugar, both feeds the yeast and weakens the immune response. Recurrent yeast infections should prompt screening for diabetes.[8]
A yeast infection causes external itching, burning, and thick discharge, while a urinary tract infection causes internal symptoms such as burning with urination, frequency, urgency, and sometimes blood or suprapubic pain, typically with little to no vaginal discharge. The two can coexist, so testing matters.[1]
References
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50. doi:10.1093/cid/civ933
- Gonçalves B, Ferreira C, Alves CT, Henriques M, et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905-927. doi:10.3109/1040841X.2015.1091805
- Foxman B, Muraglia R, Dietz JP, Sobel JD. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from the first global systematic survey. J Low Genit Tract Dis. 2013;17(1):45-52. doi:10.1097/LGT.0b013e318273e8cf
- Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(10):e339-e347. doi:10.1016/S1473-3099(18)30103-8
- Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002;99(3):419-425. doi:10.1016/s0029-7844(01)01759-8
- Abbott J. Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med. 1995;25(5):587-591. doi:10.1016/s0196-0644(95)70168-0
- Patel DA, Gillespie B, Sobel JD, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy. Am J Obstet Gynecol. 2004;190(3):644-653. doi:10.1016/j.ajog.2003.11.027
- Rautemaa-Richardson R, Sobel JD, Stone N, et al. State-of-the-Art Review: Managing Vulvovaginal Candidiasis. Clin Infect Dis. 2026. doi:10.1093/cid/ciaf673
- Akinosoglou K, Livieratos A, Asimos K, et al. Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management. Pharmaceutics. 2024;16(12):1555. doi:10.3390/pharmaceutics16121555
- Hussen I, Aliyo A, Abbai MK, Dedecha W. Vaginal candidiasis prevalence, associated factors, and antifungal susceptibility patterns among pregnant women. BMC Pregnancy Childbirth. 2024;24. doi:10.1186/s12884-024-06844-x
- Chayachinda C, Thamkhantho M, Rekhawasin T, Klerdklinhom C. Sertaconazole 300 mg versus clotrimazole 500 mg vaginal suppository for treating vulvovaginal candidiasis in pregnant women: a randomized controlled trial. BMC Pregnancy Childbirth. 2024;24. doi:10.1186/s12884-024-06440-z